✦ LIBER ✦

Recent incidence trends for breast cancer in women and the relevanceof early detection: An update

✍ Scribed by Barry A. Miller; Eric J. Feuer; Benjamin F. Hankey

Book ID: 115069553
Publisher: American Cancer Society
Year: 1993
Tongue: English
Weight: 818 KB
Volume: 43
Category: Article
ISSN: 0007-9235
DOI: 10.3322/canjclin.43.1.27

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is breast cancer incidence increasing am

Is breast cancer incidence increasing among young women? An analysis of the trend in France for the period 1983–2002

✍ Marc Colonna; Patricia Delafosse; Zoé Uhry; Florence Poncet; Patrick Arveux; Flo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Women and medicalisation: An empirical e

Women and medicalisation: An empirical examination of the extent of women's dependence on medical technology in the early detection of breast cancer

✍ Michael Calnan 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 958 KB

2037 POSTER The effect of hypofractionat

2037 POSTER The effect of hypofractionation and radiation dosimetry on the incidence of symptomatic rib fractures in women treated with radiotherapy for early breast cancer in the UK standardisation of breast radiotherapy (START) Trials

✍ P.A. Lawton; E. Aird; J. Bliss; J. Haviland; B. Magee; M. Sydenham; K. Venables; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Anastrozole alone or in combination with

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer : Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses

✍ The ATAC (Arimidex; Tamoxifen Alone or in Combination) Trialists' Group 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract ## BACKGROUND The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow‐up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer, anastrozole was superior to tamoxifen in terms of d

Effects of the addition of gemcitabine,

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial

✍ Earl, Helena M; Vallier, Anne-Laure; Hiller, Louise; Fenwick, Nicola; Young, Jen 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 349 KB